The Annals of Internal Medicine |

Popular Keywords

Adolescent Medicine

Adult Diseases

Allergy Asthma and Immunology

Cardiology

Classic Clinical Research

Clinical Cardiac Electrophysiology

A case report of encephalic leukocytoclastic vasculitis treated with sunitinib for renal cell carcinoma.

Correspondence to Author: Alessacnacdro Rizzo,

Division of Oncology, IRCCS Azienda OspedalieroUniversitaria di Bologna, Via Albertoni—15,40138 Bologna, Italy.

Introduction: A malignant tumor that develops in the kidney parenchyma is called renal cell carcinoma. Sunitinib has long been the cornerstone of medical care for metastatic renal cell carcinoma. This case report details the development of encephalic leukocytoclastic vasculitis in a 66-year-old lady with metastatic clear cell renal cancer who was treated with sunitinib for two years.likely as a result of a paraneoplastic illness.
Clear cell renal cell carcinoma (ccRCC) is the most common histological type of renal malignancy, accounting for about 75–80% of cases of renal cell carcinoma (RCC), a malignant tumor that arises in the kidney parenchyma [1].instances [2]. In Western nations, RCC is currently the seventh most prevalent cancer type in men and the tenth in women. About 25–30% of patients had metastatic disease at the time of diagnosis.

Keywords: encephalic vasculitis; sunitinib; renal cell carcinoma (RCC); leukocytoclastic vasculitis; paraneoplastic syndrome.

Citation:

Alessacnacdro Rizzo. A case report of encephalic leukocytoclastic vasculitis treated with sunitinib for renal cell carcinoma. The Annals of Internal Medicine 2024.